SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 20 filers reported holding SOLENO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000 | -16.7% | 54,695 | +81.0% | 0.00% | – |
| Q4 2021 | $12,000 | -20.0% | 30,211 | +85.3% | 0.00% | – |
| Q3 2021 | $15,000 | +1400.0% | 16,306 | +1595.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.9% | 962 | -97.4% | 0.00% | – |
| Q1 2021 | $47,000 | +147.4% | 36,976 | +269.6% | 0.00% | – |
| Q4 2020 | $19,000 | -66.7% | 10,005 | -55.7% | 0.00% | – |
| Q3 2020 | $57,000 | +39.0% | 22,596 | +21.2% | 0.00% | – |
| Q2 2020 | $41,000 | +215.4% | 18,643 | +252.6% | 0.00% | – |
| Q1 2020 | $13,000 | +160.0% | 5,287 | +196.0% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 1,786 | -62.3% | 0.00% | – |
| Q3 2019 | $7,000 | -41.7% | 4,735 | +7.3% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 4,411 | -23.8% | 0.00% | – |
| Q1 2019 | $12,000 | +300.0% | 5,789 | +183.9% | 0.00% | – |
| Q4 2018 | $3,000 | -66.7% | 2,039 | -48.7% | 0.00% | – |
| Q2 2018 | $9,000 | +125.0% | 3,975 | +67.4% | 0.00% | – |
| Q1 2018 | $4,000 | – | 2,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $9,500,000 | 2.16% |
| Nantahala Capital Management | 9,765,129 | $9,028,000 | 0.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $1,971,000 | 0.24% |
| Granite Point Capital Management, L.P. | 701,838 | $649,000 | 0.05% |
| OPPENHEIMER & CO INC | 639,140 | $591,000 | 0.01% |
| Ikarian Capital, LLC | 121,694 | $112,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $28,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $9,000 | 0.01% |
| Ergoteles LLC | 74,525 | $69,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 744,000 | $688,000 | 0.00% |